Amarin Corp Plc (AMRN)

[ziploc_1]

The thing I liked least about the teleconference this AM was the apparent message that reclaiming the U.S. market was out of the equation for Amarin.
Whichever BP buys Amarin should have a CEO for the U.S. and one for Europe and ROW

In the U.S.,The following should be under consideration.....
1.An AG for Vascepa
2. replacing Vascepa with MND2119
3. A FDC with a statin and Vascepa
4. A FDC with a statin and MND-2119
5. Indications for other diseases with an inflammatory component....such as Alzheimers, rheumatoid arthritis, cancer, dry eyes etc.
6. The acquiring company needs to return to having reps and TV adds to market its products.

Amarin absolutely can not do these things alone...It has to sell to a BP.